-
Jingwei Bian1，Zijian Li1,2（Department of Cardiology and Institute of Vascular Medicine，Peking University Third Hospital，Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides，Ministry of Health，Key Laboratory of Molecular Cardiovascular Sciences，Ministry of Education，Beijing Key Laboratory of Cardiovascular Receptors Research；Department of Pharmacy，Peking University Third Hospital）.Angiotensin-converting enzyme 2(ACE2)：SARS-CoV-2 receptor and RAS modulator[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Shuang Zhou1，Jinbo Li1，Jiang Yu1，Liyuan Yang1，Xiao Kuang1，Zhenjie Wang1，Yingli Wang1，Hongzhuo Liu1，Guimei Lin2，Zhonggui He1，Dan Liu3，Yongjun Wang1（Wuya College of Innovation，Shenyang Pharmaceutical University；School of Pharmaceutical Science，Shandong University；Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education，Shenyang Pharmaceutical University）.A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Jie Cheny，Yan Wangy，Di Zhao，Lingyuan Zhang，Weimin Zhang，Jiawen Fan，Jinting Li，Qimin Zhan（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)，Laboratory of Molecular Oncology，Peking University Cancer Hospital & Institute）.Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma(ESCC)[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Zhibin Yan1，Dan Wang1，Chunmei An1，Hongjiao Xu2，Qian Zhao2，Ying Shi2，Nazi Song2，Bochuan Deng1，Xiaomin Guo1，Jing Rao1，Lu Cheng1，Bangzhi Zhang1，Lingyun Mou1，Wenle Yang1，Xianxing Jiang2，Junqiu Xie1（Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences &Research Unit of Peptide Science，Chinese Academy of Medical Sciences，2019RU066，Lanzhou University；School of Pharmaceutical Sciences，Sun Yat-sen University）.The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Yu Sun1，Jiahua Qian2（Department of Traditional Chinese Medicine and Ethnopharmaceuticals，Center for Drug Evaluation，National Medical Products Administration；Center for Drug Evaluation，National Medical Products Administration）.Botanical drug clinical trial：Common issues and future options[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Zeqi Zhou1，Xiangbin Wang2，Yankai Fu1，Xiqing Zhang1，Changxiao Liu3（Dynamiker Biotechnology Sub-Center，Beijing Key Laboratory for Mechanism Study and Precision Diagnosis of Invasive Fungal Diseases；Beijing Antai Zhiyuan Technology Co.，Ltd.；State Key Laboratory of Drug Delivery Technology and Pharmacokinetics，Tianjin Institute of Pharmaceutical Research）.Letter to the editor：Neutralizing antibodies for the treatment of COVID-19[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2021,第1期
|